LabcorpLHEarnings & Financial Report
Labcorp is a leading global life sciences and diagnostic testing firm that offers comprehensive clinical laboratory services, drug development support, and medical testing solutions for healthcare providers, pharmaceutical companies, and individual patients. It uses advanced scientific expertise and innovative technologies to deliver accurate, actionable health insights that support clinical decisions, accelerate new treatment development, and improve patient health outcomes globally.
LH Q4 FY2025 Key Financial Metrics
Revenue
$3.5B
Gross Profit
$993.2M
Operating Profit
$267.6M
Net Profit
$164.7M
Gross Margin
28.2%
Operating Margin
7.6%
Net Margin
4.7%
YoY Growth
5.6%
EPS
$1.98
Labcorp Q4 FY2025 Financial Summary
Labcorp reported revenue of $3.5B (up 5.6% YoY) for Q4 FY2025, with a net profit of $164.7M (up 14.9% YoY) (4.7% margin). Cost of goods sold was $2.5B, operating expenses totaled $725.6M.
Key Financial Metrics
| Total Revenue | $3.5B |
|---|---|
| Net Profit | $164.7M |
| Gross Margin | 28.2% |
| Operating Margin | 7.6% |
| Report Period | Q4 FY2025 |
Revenue Breakdown
Labcorp Q4 FY2025 revenue of $3.5B breaks down across 2 segments, led by Diagnostics at $2.7B (77.6% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Diagnostics | $2.7B | 77.6% |
| Biopharma Laboratory Services | $793.0M | 22.6% |
Labcorp Revenue by Segment — Quarterly Trend
Labcorp revenue by segment across the last 4 reported quarters, showing how each business line (such as Diagnostics and Biopharma Laboratory Services) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Diagnostics | $2.7B | $2.8B | $2.7B | $2.6B |
| Biopharma Laboratory Services | $793.0M | $799.1M | $784.8M | $721.3M |
Labcorp Annual Revenue by Year
Labcorp annual revenue history includes year-by-year totals (for example, 2025 revenue was $14.0B).
Labcorp Quarterly Revenue & Net Profit History
Labcorp results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $3.5B | +5.6% | $164.7M | 4.7% |
| Q3 FY2025 | $3.6B | +8.6% | $261.1M | 7.3% |
| Q2 FY2025 | $3.5B | +9.5% | $237.9M | 6.7% |
| Q1 FY2025 | $3.3B | +5.3% | $212.8M | 6.4% |
| Q4 FY2024 | $3.3B | +45.2% | $143.4M | 4.3% |
| Q3 FY2024 | $3.3B | +7.4% | $169.3M | 5.2% |
| Q2 FY2024 | $3.2B | +6.2% | $205.3M | 6.4% |
| Q1 FY2024 | $3.2B | -15.9% | $228.0M | 7.2% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.18B | $3.22B | $3.28B | $3.33B | $3.35B | $3.53B | $3.56B | $3.52B |
| YoY Growth | -15.9% | 6.2% | 7.4% | 45.2% | 5.3% | 9.5% | 8.6% | 5.6% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $16.53B | $16.71B | $18.61B | $18.38B | $17.60B | $18.06B | $18.26B | $18.39B |
| Liabilities | $8.56B | $8.69B | $10.43B | $10.31B | $9.28B | $9.57B | $9.55B | $9.76B |
| Equity | $7.96B | $8.01B | $8.17B | $8.05B | $8.31B | $8.47B | $8.70B | $8.62B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-29.8M | $561.1M | $277.3M | $777.2M | $18.5M | $620.6M | $387.2M | $614.2M |